BTIG Reiterates Buy on DexCom (DXCM) Following Announced Medicare Coverage
Tweet Send to a Friend
BTIG reiterated a Buy rating and $92.00 price target on DexCom (NASDAQ: DXCM) following the company's announced determination and coverage ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
